Category: Medical

iCarbonX Pharmaceutical Initiates Phase I Clinical Study of Antimicrobial Peptide Drug Candidate iCAMP016 On May 8, 2026, the initiation meeting for the Phase I clinical study of iCAMP016, an antimicrobial peptide drug candidate developed by iCarbonX Pharmaceutical,…

Health Management and Intervention Products